Skip to main content

Advertisement

SpringerLink
Log in

Reflections on tumor origin, immunogenicity, and immunotherapy

  • Review
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baldwin RW, Price MR (1976) Immunobiology of rat neoplasia. Ann NY Acad Sci 276:3

    Google Scholar 

  2. Brosman SA (1982) Experience with BCG in patients with superficial bladder cancer. J Urol 128:27

    Google Scholar 

  3. Cabilly S, Riggs AD, Pande H, Shively JE, Holmes WmE, Rey M, Perry LJ, Wetzel R, Heyneker HL (1984) Recombinant antibodies. I. Generation of antibody activity from immunoglobulin peptide chains produced in bacteria. Proc Natl Acad Sci USA (in press)

  4. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779

    Google Scholar 

  5. Epstein LB (1981) Interferon as a model lymphokine. Fed Proc 40:56

    Google Scholar 

  6. Folkman J (1974) Tumor angiogenesis. Adv Cancer Res 19:331

    Google Scholar 

  7. Foulds L (1958) The natural history of cancer. J Chronic Dis 8:2

    Google Scholar 

  8. Heppner GH, Miller BE (1983) Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev 2:5

    Google Scholar 

  9. Hewitt HB (1980) Book review. Br J Cancer 42:627

    Google Scholar 

  10. Hewitt HB, Blake ER, Walder AS (1976) A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer 33:241

    Google Scholar 

  11. Israël L, Edelstein R (1978) In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality. Isr J Med Sci 14:105

    Google Scholar 

  12. Kedar E, Weiss DW (1983) The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy. Adv Cancer Res 38:171

    Google Scholar 

  13. Kedar E, Chriqui-Zeira E, Weiss DW, Kyriazis AP (1984) Immunotherapy of murine and human tumors growing in mice with lymphokines and IL-2 propagated lymphocytes. J Biol Resp Mod (in press)

  14. Klein B, Devens B, Deutsch O, Ahituv A, Frenkel S, Kobrin BJ, Naor D (1981) Isolation of immunogenic and suppressogenic determinants of the nonimmunogenic YAC tumor and the change in its immunogenic repertoire after in vitro cultivation. Transplant Proc 13:790

    Google Scholar 

  15. Klein G, Klein E (1977) Immune surveillance against virus induced tumors and nonrejectability of spontaneous tumors: Contrasting consequences of host versus tumor evolution. Proc Natl Acad Sci USA 74:2121

    Google Scholar 

  16. Klein G, Klein E (1984) Oncogene activation and tumor progression. (in press)

  17. Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596

    Google Scholar 

  18. Logan J, Cairns J (1982) The secrets of cancer. Nature 300:104

    Google Scholar 

  19. Markson Y, Weiss DW, Weiss O, Doljanski F (1984) Shedding of cell surface antigens from human colon carcinoma cells growing in athymic mice. Human Immunol (in press)

  20. Morton DL (1984) Tumor debulking as immunotherapeutic measure. Trans Proc (in press)

  21. Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23

    Google Scholar 

  22. Ruley HE (1983) Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602

    Google Scholar 

  23. Schmitt M, Daynes RA (1982) Heterogeneity of tumorigenicity phenotype in murine tumors. Transplantation 33:387

    Google Scholar 

  24. Sulitzeanu D (1984) Human cancer-associated antigens: Present status and implications for immunodiagnosis. Adv Cancer Res (in press)

  25. Sulitzeanu D, Weiss DW (1981) Antigen and immunogen. A question of terminology. Cancer Immunol Immunother 11:291

    Google Scholar 

  26. Terman DS, Young JB, Sherer WT, Ayus C, Lehande D, Mattioli C, Espada R, Howell JF, Yamamoto T, Zaleski HI, Miller L, Frommer P, Feldman L, Henry JF, Tillquist R, Cook G, Daskal Y (1981) Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. N Engl J Med 305:1195

    Google Scholar 

  27. Waters H (ed) (1978) The handbook of cancer immunology, vol 2: Cellular escape from immune destruction. Garland STPM Press, New York

    Google Scholar 

  28. Weiss DW (1978) Animal models of cancer immunotherapy: Some considerations. In: Immunotherapy of Human Cancer, University of Texas System Cancer Center 22nd Annual Clinical Conference on Cancer. Raven, New York, pp 101–109

    Google Scholar 

  29. Weiss DW (1980) Tumor antigenicity and approaches to tumor immunotherapy. An outline. Curr Top Microbiol Immunol 89:1

    Google Scholar 

  30. Weiss DW (1984a) Tumor origin, progression, immunogenicity, and immunotherapy. Transplant Proc (in press)

  31. Weiss DW (1984) Nonspecific immunity and cancer. In: Wayne LG, Kubica JP (eds) The mycobacteria — A sourcebook. Dekker, New York

    Google Scholar 

  32. Zimber C, Ben-Efraim S, Grover NB, Weiss DW (1981) Prevention by the MER tubercle bacillus fraction of immuno-suppression induced by cancer chemotherapeutic agents. III. Contact hypersensitivity to dinitrofluorobenzene in mice treated with methotrexate, 5-fluorouracil, or cyclophosphamide, or exposed to dinitrobenzenesulfonate. Cancer Immunol Immunother 10:147

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Lautenberg Center for General and Tumor Immunology, Hebrew University — Hadassah Medical School, Jerusalem, Israel

    David W. Weiss

Authors
  1. David W. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weiss, D.W. Reflections on tumor origin, immunogenicity, and immunotherapy. Cancer Immunol Immunother 18, 1–4 (1984). https://doi.org/10.1007/BF00205391

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205391

Keywords

Search

Navigation